MyAverix Finance
F · Healthcare
HUTCHMED (CHINA) LS-1 (H7T2)
Drug Manufacturers - Specialty & Generic
HUTCHMED (CHINA) LS-1 (H7T2) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $1.89B, P/E ratio is 4.78, net margin is 83.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for H7T2
HUTCHMED (CHINA) LS-1 (H7T2) — FAQ
What is HUTCHMED (CHINA) LS-1's market cap?
HUTCHMED (CHINA) LS-1 (H7T2) has a reported market cap of $1.89B (data as of 2026-03-29).
What is H7T2's P/E ratio?
The price-to-earnings (P/E) ratio for HUTCHMED (CHINA) LS-1 (H7T2) is 4.78 (data as of 2026-03-29).
Does HUTCHMED (CHINA) LS-1 pay a dividend?
Dividend yield is not available in the current snapshot for HUTCHMED (CHINA) LS-1 (H7T2). Check the MyAverix Finance app for the latest dividend data.
What sector is HUTCHMED (CHINA) LS-1 in?
HUTCHMED (CHINA) LS-1 (H7T2) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is H7T2 listed on?
H7T2 is listed on F.
What is HUTCHMED (CHINA) LS-1's net margin?
HUTCHMED (CHINA) LS-1 (H7T2) reports a net margin of 83.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.